Page last updated: 2024-09-04

olmesartan and Angina, Stable

olmesartan has been researched along with Angina, Stable in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hirohata, A; Ito, H; Komatsubara, I; Kusachi, S; Miyoshi, T; Murakami, T; Nakamura, K; Ohe, T; Usui, S; Yamamoto, K	1

Trials

1 trial(s) available for olmesartan and Angina, Stable

Article	Year
Olmesartan reduces inflammatory biomarkers in patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the OLIVUS trial. Heart and vessels, 2014, Volume: 29, Issue:2 Topics: Adiponectin; Aged; Angina, Stable; Angiotensin II Type 1 Receptor Blockers; Anti-Inflammatory Agents; Biomarkers; C-Reactive Protein; Coronary Artery Disease; Coronary Vessels; Disease Progression; Down-Regulation; Female; Humans; Imidazoles; Inflammation Mediators; Japan; Male; Middle Aged; Percutaneous Coronary Intervention; Plaque, Atherosclerotic; Prospective Studies; Tetrazoles; Time Factors; Treatment Outcome; Ultrasonography, Interventional	2014

Article

Year

Olmesartan reduces inflammatory biomarkers in patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the OLIVUS trial.

Heart and vessels, 2014, Volume: 29, Issue:2

Topics: Adiponectin; Aged; Angina, Stable; Angiotensin II Type 1 Receptor Blockers; Anti-Inflammatory Agents; Biomarkers; C-Reactive Protein; Coronary Artery Disease; Coronary Vessels; Disease Progression; Down-Regulation; Female; Humans; Imidazoles; Inflammation Mediators; Japan; Male; Middle Aged; Percutaneous Coronary Intervention; Plaque, Atherosclerotic; Prospective Studies; Tetrazoles; Time Factors; Treatment Outcome; Ultrasonography, Interventional

2014